Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 May;82(1):35–42. doi: 10.1111/j.1476-5381.1984.tb16439.x

Effects of dopamine and bromocriptine on colonic motility in dog.

L Bueno, M J Fargeas, J Fioramonti, C Honde
PMCID: PMC1987238  PMID: 6145468

Abstract

The effects of intravenous infusions of dopamine (0.1 to 1 mg kg-1h-1) and bromocriptine (10 to 40 micrograms kg-1h-1) on colonic motility were investigated in fasted dogs fitted with permanent strain gauges on the ascending, transverse and descending colon. Infused at rates of 0.5 and 1 mg kg-1h-1 during 1 h, dopamine immediately stimulated the motility of the descending colon; after a delay of 40 to 60 min this effect was balanced by an inhibition of the motility of the ascending and transverse colon. Bromocriptine infused intravenously at doses of 10 to 40 micrograms kg-1h-1 stimulated the motility of the whole colon but these effects were limited to the duration of the infusion (60 min). Both propranolol (0.5 mg kg-1) and tolazoline (2 mg kg-1) failed to block the effects of dopamine and bromocriptine whereas phentolamine (0.1 mg kg-1) and prazosin (0.2 mg kg-1) partially reduced the inhibitory effects of dopamine on the proximal colon. Haloperidol at doses higher than 0.2 mg kg-1 and domperidone blocked the bromocriptine-induced stimulation of colonic motility which was unaffected by previous treatment with alpha- and beta-adrenoceptor blocking agents. These results suggest that in the dog, dopamine and bromocriptine stimulate colonic motility through specific dopamine receptors. However, they suggest that the inhibitory effects of dopamine on the proximal colon which are blocked by dopamine antagonists are also partially due to an effect on alpha 1-adrenoceptors.

Full text

PDF
35

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cox B., Ennis C. Mechanism of action of dopamine on the guinea-pig gastro-oesophageal junction in vitro. Br J Pharmacol. 1980;71(1):177–184. doi: 10.1111/j.1476-5381.1980.tb10923.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. FINK S., FRIEDMAN G. The differential effect of drugs on the proximal and distal colon. Am J Med. 1960 Apr;28:534–540. doi: 10.1016/0002-9343(60)90147-9. [DOI] [PubMed] [Google Scholar]
  3. Goldberg L. I. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev. 1972 Mar;24(1):1–29. [PubMed] [Google Scholar]
  4. György L., Orr Z., Dóda M. Influence of dopamine and dopaminergic agonists on relaxation of isolated rabbit ileum induced by sympathetic nerve stimulation. Acta Physiol Acad Sci Hung. 1981;58(2):163–168. [PubMed] [Google Scholar]
  5. Lanfranchi G. A., Marzio L., Cortini C., Osset E. M. Motor effect of dopamine on human sigmoid colon. Evidence for specific receptors. Am J Dig Dis. 1978 Mar;23(3):257–263. doi: 10.1007/BF01072326. [DOI] [PubMed] [Google Scholar]
  6. Latour A., Bueno L. A micro-computerised system to measure the colonic contractile activity: application to pharmacological tests in dogs. Int J Biomed Comput. 1980 Sep;11(5):389–396. doi: 10.1016/0020-7101(80)90054-9. [DOI] [PubMed] [Google Scholar]
  7. Lechin F., Van Der Dijs B., Bentolila A., Peña F. Antidiarrheal effects of dihydroergotamine. J Clin Pharmacol. 1977 May-Jun;17(5-6):339–349. doi: 10.1002/j.1552-4604.1977.tb04614.x. [DOI] [PubMed] [Google Scholar]
  8. Lechin F., Van Der Dijs B., Bentolila A., Peña F. The "spastic colon" syndrome: therapeutic and pathophysiologic considerations. J Clin Pharmacol. 1977 Jul;17(7):431–440. doi: 10.1002/j.1552-4604.1977.tb04626.x. [DOI] [PubMed] [Google Scholar]
  9. Lechin F., Van Der Dijs B. Effects of dopaminergic blocking agents on distal colon motility. J Clin Pharmacol. 1979 Oct;19(10):617–625. doi: 10.1002/j.1552-4604.1979.tb01624.x. [DOI] [PubMed] [Google Scholar]
  10. Pascaud X. B., Genton M. J., Bass P. A miniature transducer for recording intestinal motility in unrestrained chronic rats. Am J Physiol. 1978 Nov;235(5):E532–E538. doi: 10.1152/ajpendo.1978.235.5.E532. [DOI] [PubMed] [Google Scholar]
  11. Riddall D. R., Leavens W. J. Affinities of drugs for the agonist and antagonist states of the dopamine receptor. Eur J Pharmacol. 1978 Sep 15;51(2):187–188. doi: 10.1016/0014-2999(78)90344-8. [DOI] [PubMed] [Google Scholar]
  12. Robertson H. A. Stimulation of 3H-apomorphine binding by dopamine and bromocriptine. Eur J Pharmacol. 1980 Jan 25;61(2):209–211. doi: 10.1016/0014-2999(80)90169-7. [DOI] [PubMed] [Google Scholar]
  13. Sahyoun H. A., Costall B., Naylor R. J. Catecholamines act as alpha 2-adrenoceptors to cause contraction of circular smooth muscle of guinea-pig stomach. J Pharm Pharmacol. 1982 Jun;34(6):381–385. doi: 10.1111/j.2042-7158.1982.tb04734.x. [DOI] [PubMed] [Google Scholar]
  14. Valenzuela J. E. Dopamine as a possible neurotransmitter in gastric relaxation. Gastroenterology. 1976 Dec;71(6):1019–1022. [PubMed] [Google Scholar]
  15. de Carle D. J., Christensen J. A dopamine receptor in esophageal smooth muscle of the opossum. Gastroenterology. 1976 Feb;70(2):216–219. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES